Why the study?
Does carotid ultrasound-based assessment of CIMT and carotid plaques improve cardiovascular disease risk prediction in asymptomatic individuals with CVD risk factors?
Does carotid ultrasound-based assessment of CIMT and carotid plaques improve cardiovascular disease risk prediction in asymptomatic individuals with CVD risk factors?
Answers are grounded in this paper and cite their sources.
Carotid ultrasound assessment of plaques and CIMT is a valuable tool for cardiovascular risk stratification and can guide the intensification of preventive therapies in asymptomatic individuals.
Carotid intima-media thickness (CIMT) and nonstenotic carotid plaques are established measures of subclinical atherosclerosis and are useful for prediction of future cardiovascular disease (CVD) risk. Compared with CIMT, the incremental predictive value of carotid plaques is more robust. Although the guidelines differ, carotid ultrasound-based assessment of CIMT and carotid plaques has a role in risk stratification and management of asymptomatic individuals who present with one or more CVD risk factors. The presence of significantly elevated CIMT or carotid plaque burden should lead to reclassification of the individuals into high-risk category with the appropriate intensification of the risk reduction measures. In addition, demonstration of increased CIMT and/or presence of the plaques may also help in improving patients' health behavior and their compliance toward antiatherosclerotic measures. In future, plaque progression/regression assessment by three-dimensional ultrasound and the use of contrast agents may further enhance the utility of carotid ultrasound for monitoring the clinical course of atherosclerotic vascular disease.
No takes yet. Share an insight, caveat, or question.
Kasliwal et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: